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Ganglio- Galβ1-3GalNAcβ1-4Galβ1-4Glc
α2-3
NeuAc
Lacto- Galβ1-3GlcNAcβ1-3Galβ1-4Glc
α2-3
NeuAc
Neolacto- Galβ1-4GlcNAcβ1-3Galβ1-4Glc
α2-3
NeuAc
Abstract. Gangliosides, as plasma membrane-
associated sialylated glycolipids, are antigenic struc-
tures and they serve as ligands for adhesion proteins
of pathogens, for toxins of bacteria, and for endoge-
nous proteins of the host. The detectability by
carbohydrate-binding proteins of glycan antigens
and ligands on glycolipids can be influenced by the
differing lipid moieties. To investigate glycan se-
quences of gangliosides as recognition structures,
we have underway a program of work to develop a
Bgangliome^ microarray consisting of isolated natural gangliosides and neoglycolipids (NGLs) derived from glycans
released from them, and each linked to the same lipid molecule for arraying and comparative microarray binding
analyses. Here, in the first phase of our studies, we describe a strategy for high-sensitivity assignment of the
tetrasaccharide backbones and application to identification of eight ofmonosialylated glycans released frombovine brain
gangliosides. This approach is based on negative-ion electrospraymass spectrometrywith collision-induced dissociation
(ESI-CID-MS/MS) of the desialylated glycans. Using this strategy, we have the data on backbone regions of four minor
components among the monosialo-ganglioside-derived glycans; these are of the ganglio-, lacto-, and neolacto-series.
Keywords: Gangliosides, Bovine brain, Negative-ion ESI-CID-MA/MS, Glycans, Oligosaccharides, Sequence assign-
ment, Backbone structures
Received: 5 March 2018/Revised: 10 March 2018/Accepted: 10 March 2018/Published Online: 11 May 2018
Introduction
Gangliosides are plasma membrane-associated andsialylated glycolipids. The glycan moieties constitute
cell surface antigens; also among them are ligands for
endogenous carbohydrate-recognition proteins, host cell
attachment sites for viruses, bacteria, and parasitic
agents, and toxins of bacteria. Certain lipid moieties
can influence the orientation and presentation of facets
of the glycans such that they may not always be acces-
sible for binding by particular carbohydrate-recognizing
proteins [1, 2]. There are occasions when the assignment
of the glycan antigens and ligands on glycolipids require
deconvolution of the glycan and lipid moieties [3].
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HPLC separation and purification, and sequence determination
by mass spectrometry (MS) and NMR of glycolipids can be
difficult due to the presence of multiple lipids. To investigate
gangliosides as recognition structures, we have underway a pro-
gram to develop a Bgangliome^ microarray using both natural
gangliosides and neoglycolipids (NGLs) [4, 5] derived from
glycans that are released from them. In the NGLs, each glycan
is linked to the same lipid molecule and arrayed in a liposomal
formulation for comparative microarray binding analyses. This is
a different strategy from that of Cummings and colleagues [6] for
generating covalently immobilized glycan microarrays.
The glycans of gangliosides can be released from their lipids
enzymatically or chemically. We favor ozonolysis followed by
alkaline hydrolysis [7] as there is a high yield of glycans irrespec-
tive of glycan sequence. The released glycans can be fractionated
by HPLC and sequenced by MS and NMR. In our NGL ap-
proach, the glycans, once purified and characterized, are conju-
gated to an amino-phospholipid and converted for arraying and
binding studies in comparison with the natural glycolipids, using
advanced microarray methodology [4]. Each NGL obtained in
this way not only contains a single carbohydrate sequence but also
a single lipid chain in order to facilitate assignment of carbohy-
drate binding specificities. This is a strategy already used success-
fully in assignment of the preferredN-glycolyl overN-acetyl GM1
for recognition by Simian virus 40 [3].
Our preliminary HPLC analyses of ganglioside-derived gly-
cans from the mono-, di-, tri-, and tetra-sialylated fractions
(GM, GD, GT, and GQ, respectively), obtained by group
separation using anion exchange, showed that each fraction
contained a few dominant components and many minor com-
ponents. Among the 188 ganglioside-derived glycan structures
reviewed in 2004 by Yu and colleagues, 29 sequences of
monosialylated gangliosides were reported as the ganglio-se-
ries from various tissues of different animals [8, 9]. In bovine
brain, there occur gangliosides with other glycan backbones,
e.g., the lacto- and neolacto-series [9] in addition to the
ganglio-series. Thus, the enormous diversity of carbohydrate
structures in gangliosides poses difficulties in separation and
characterization. As the quantity obtainable can be too low for
conventional NMR analysis, a high-sensitivity MS-based
method is highly desirable. In this presentation, we explore
the negative-ion electrospraymass spectrometry with collision-
induced dissociation (ESI-CID-MS/MS) method, previously
developed for both neutral [10, 11] and sialylated oligosaccha-
rides [12], for assignment of the glycan backbone sequences of
monosialylated gangliosides.
Here, we describe a new strategy for backbone assign-
ment of monosialylated oligosaccharides released from
bovine brain gangliosides. This takes advantage of the
wealth of sequence information obtainable from neutral
oligosaccharides by negative-ion ESI-CID-MS/MS after
chemical desialylation. Using this strategy, we have iden-
tified the major and some of the very minor components of
bovine brain gangliosides. The results indicate that the
diversity of carbohydrate structures of gangliosides in bo-
vine brain is more complex than anticipated.
Experimental
Materials
Sialylated pentasaccharide standards LSTa, LSTb, and LSTc
were purchased from Dextra Laboratories (Reading, UK), and
GM1a and LSTd from Elicityl (Grenoble, France).
Trifluoroacetic acid (TFA) of ReagentPlus grade was from
Sigma-Aldrich (Gillingham, UK). All solvents used were of
HPLC grade.
Monosialylated Oligosaccharides from Bovine
Brain Glycolipids
Oligosaccharides were released from total bovine brain glyco-
lipids by ozonolysis followed by alkaline hydrolysis as de-
scribed [7]. In brief, bovine brain glycolipids were dissolved
at 5 mg/ml in methanol and subjected to ozonolysis as de-
scribed. Triethanolamine was added to adjust the pH to 10 and
the reaction mixture was kept at ambient temperature for 24 h.
The released glycans were fractionated by DEAE-Sepharose
chromatography to obtain the monosialylated glycan fraction.
HPLC Fractionation
Individual monosialylated oligosaccharides were isolated by
hydrophilic interaction liquid chromatography (HILIC) on an
amide column (3.5 μm, 4.6 × 250 mm, XBridge, from Waters,
Manchester, UK). Elution was performed with a linear gradient
of CH3CN/H2O (solvent A, 70:30, solvent B, 20: 80, by vol)
containing 15 mM KH2PO4, from 3 to 8% B over 50 min at a
flow rate of 1 ml/min, monitored by UV at 196 nm [13].
Fractions were desalted by gel filtration on a Superdex Peptide
column (GE Healthcare Life Sciences, Little Chalfont, UK)
with elution by NH4OAc (0.2 M) at a flow rate of 0.2 ml/min
with online detection by refractive index.
Pooled HILIC fractions were further purified by HPLC
using a porous graphitized carbon (PGC) column (Hypercarb,
5 μm, 4.6 × 30 mm, from Hypersil, Runcorn, UK). A gradient
of acetonitrile was used for elution (solvent A, H2O; solvent B,
CH3CN/H2O H2O/acetonitrile 20:80; both containing 0.05%
TFA; 5–17% B in 35 min) at a flow rate of 1 ml/min, with
detection by UV at 206 nm.
Quantitation based on hexose content was by dot-orcinol
assay as described [14].
Desialylation by Mild Acid Hydrolysis
Removal of sialic acid from the sialylated glycans was carried
out by a chemical method using TFA [15]. Briefly, a 1 nmol
glycan in 10 μl solution was added with 1 μl of 10% TFA. The
solution was kept at 80 °C for 45 min before it was dried under
a N2 stream. To ensure complete removal of TFA, a further
20 μl of water was added and the solution was dried again
under a N2 stream. The desialylated glycan was dissolved in
50 μl and 1 μl was used for ESI-MS and CID-MS/MS.
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Electrospray Ionization Mass Spectrometry
Negative-ion ESI-MS and collision-induced dissociation (CID)
MS/MS were carried out on a Q-TOF or a Synapt G2 mass
spectrometer (Waters, Manchester, UK). Nitrogen was used as
desolvation and nebulizer gas at a flow rate of 250 and 15 l/h,
respectively. Source temperature was 80 °C and the
desolvation temperature 150 °C. The capillary voltage was
maintained at 3 kV. A cone voltage of 50–80 V was used for
CID-MS/MS. A scan rate of 1 s/scan was employed for CID-
MS/MS experiments and the acquired spectra were summed
for presentation.
Product-ion spectra were obtained from CID with argon as
the collision gas at a pressure of 1.7 bar. The collision energy
was adjusted between 16 and 38 V for optimal fragmentation
for the tetra- to heptasaccharides. For analysis, oligosaccha-
rides were dissolved in H2O at a concentration of 10–20 pmol/
μl, of which 1 μl was loop-injected. Solvent (CH3CN/2 mM
NH4HCO3 1:1) was delivered by a syringe pump at a flow rate
of 10 μl/min.
Results and Discussion
Isolation and Characterization of Sialylated Gly-
cans from Bovine Brain Gangliosides
Sialylated glycans were released from extracted total
bovine brain glycolipids by ozonolysis and alkaline hy-
drolysis. Monosialylated fraction was isolated from these
glycans by anion exchange. Further separation of the
monosialylated oligosaccharides was carried out by
HILIC on an amide column. As shown in Figure 1a,
fraction 8 was the dominant component (83.6%); frac-
tions 4 (2.5%) and 10 (9.4%) were also apparent. In an
expanded view, 24 fractions were revealed (Figure 1b);
the majority is very minor, and these represent less than
4.5% of the total.
Selected HILIC fractions were subjected to further HPLC
analysis on a PGC column. The chromatogram obtained for
fraction 8 indicated a pure component with well-separated α-
and β-forms as predicted [16]; the α-anomer at 33.0 min and β-
anomer at 37.7 min (Figure 2a). However, fraction 10 showed
three components: 10a, 10b, and 10c, each with α- and β-
anomers resolved (Figure 2b).
The multiplicity of the components among the
monosialylated glycans of the brain gangliosides and
the small amounts of materials available pose a consid-
erable challenge to structural elucidation. Conventional
methods such as NMR are not possible. Initial
negative-ion ESI-CID-MS/MS was unsuccessful as the
product-ion spectra were dominated by desialylation and
the very weak fragment ions obtained were too complex
to be used for sequence assignment (Suppl Figures 1–3).
Therefore, a new MS-based approach was required.
Unique Fragmentation Patterns for Different
Tetrasaccharide Backbone Sequences
As neutral reducing glycans can produce reliable and very
informative fragmentation [10, 17], microscale chemical
AU
0.00
0.50
1.00
1.50
2.00
(Min)0 5 10 15 20 25 30 35 40 45
4
8
10
11 13
AU
0.000
0.025
0.050
0.075
0.100
(Min)0 5 10 15 20 25 30 35 40 45
1
2
3
4
65
8 10
7 9 11
12
13
15
17
1814 19
2220
24
2116 23
(a)
(b)
(
U
V
 1
9
6
 n
m
)
(
U
V
 1
9
6
 n
m
)
Figure 1. Fractionation of monosialylated glycans obtained
from bovine brain gangliosides after cleavage of the ceramide
chains by HILIC (amide) and anion-exchange. (a) HILIC profile
and (b) expanded view (intensity × 20)
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Figure 3. Negative-ion ESI product-ion spectra of tetrasaccharide backbones of the ganglio- (a), lacto- (b), and neolacto-series (c)
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desialylation was carried out before negative-ion ESI-CID-MS/
MS. The sialylation information is lost but important backbone
sequence information is available. Five monosialylated glycans
(Table 1) were selected as reference compounds to establish the
fragmentation.
GM1a contains the ganglio-tetrasaccharide sequence
Gal1-3GalNAc1-4Gal1-4Glc, and LS tetrasaccharides
LSTa and LSTb contain the lacto-sequence, Gal1-
3GlcNAc1-3Gal1-4Glc, whereas LSTc and LSTd contain
the neolacto-sequence Gal1-4GlcNAc1-3Gal1-4Glc. Apart
from the different internal HexNAc residues (GalNAc in
the ganglio-series and GlcNAc in the four LS
tetrasaccharides), the main difference among the three
tetrasaccharide backbones is the difference in the glyco-
sidic linkages, B3-4-4^ for the ganglio-, B3-3-4^ for the
lacto-, and B4-3-4^ for the neolacto-series.
Negative-ion ESI-CID product-ion spectra (Figure 3) can be
used to identify the backbone sequences via detailed linkage
assignment. All three backbone structures gave glycosidic C-
ions (C1 at m/z 179, C2 at m/z 382, and C3 at m/z 544) that
indicate a linear tetrasaccharide sequence. As all three have a 4-
linked Glc at the reducing end, their reducing terminal frag-
mentations, 2,4A4 at m/z 586 and
0,2A4, together with its
dehydrated satellite, at m/z 646/628, are identical to the three
backbone structures. These three A-type fragment ions with
neutral loss of − 60/78/120 from the molecular ion [M–H]− at
m/z 706 are characteristic of a 4-linked Hex residue [11].
In the spectrum of desialylated GM1a glycan (Figure 3a), a
further set of fragments with neutral loss of − 60/78/120
from C3 (m/z 544) at m/z 424/466/484 (
2,4A3 and
0,2A3) is
observed for the second residue from the reducing end of
this B3-3-4^ linked tetrasaccharide. In the spectrum of
Table 1. Monosialylated Oligosaccharides Used to Establish Negative-Ion
ESI-CID-MS/MS Fragmentation
Oligosaccharides Sequences
Ganglio-series
GM1a-glycan Galβ1-3GalNAcβ1-4Galβ1-4Glc
α2-3
NeuAc
Lacto-series
LSTa Galβ1-3GlcNAcβ1-3Galβ1-4Glc
α2-3
NeuAc
NeuAc
α2-6
LSTb Galβ1-3GlcNAcβ1-3Galβ1-4Glc
Neolacto-series
NeuAc
α2-6
LSTc Galβ1-4GlcNAcβ1-3Galβ1-4Glc
LSTd Galβ1-4GlcNAcβ1-3Galβ1-4Glc
α2-3
NeuAc
The colors highlight the different backbone structures: ganglio-series in blue,
lacto-series in red, and neolacto-series in green
Table 2. Negative-Ion ESI-MS of Monosialylated Glycans Obtained from Bovine Brain Glycolipids and CID-MS/MS After Desialylation to Assign the Backbone
Sequences
?HexNAc 1  O  ?Gal 1  O  ?Glc
HPLC Glycans [M H] [M SA H] C1 C2 C3 C4
2,4
AR-2
0,2
AR-2
2,4
AR-1
0,2
AR-1
2,4
AR
0,2
AR
Ganglio-series
8 GM1a 997 706 179 382 544 424 466/484 586 628/646
10c GM1b 997 706 179 382 544 424 466/484 586 628/646
10a GM1a (NeuGc) 1013 706 179 382 544 424 466/484 586 628/646
10b Fuc-GM1 1143 852 163 325 528 690 570 612/630 732 774/792
11 GalNAc-GM1 1200 909 220 382 585 747 627 669/687 789 831/849
3-linkage 4-linkage 4-linkage
Neolacto-series
12 GalNAc-nLc4 1200 909 220 382 585 747 424 466/484 789 831/849
4-linkage 3-linkage 4-linkage
Lacto-series
13 GalNAc2-Lc4 1403 1112 220 382 585 950 992 1034/1052
20 Gal.GalNAc2-Lc4 1565 1274 220 382 585 1112 1154 1196/1214
3-linkage 3-linkage 4-linkage
[M–H]−: deprotonated ion identified by ESI-MS of monosialyl glycolipid-derived glycans; [M–SA–H]−: deprotonated ion identified by ESI-MS of monosialylated
after chemical desialylation, and used as the precursor ion for CID-MS/MS
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Figure 4. Negative-ion ESI product-ion spectra of desialylated glycans with the ganglio-backbones obtained from bovine brain
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LSTa, this additional set of − 60/78/120 was absent as the
internal Gal is 3-linked and this linkage is known not to
produce A-type fragments [11] (Figure 3b). As the internal
GlcNAc is 3-linked, a double glycosidic cleavage was
observed to give a D1–2 ion at m/z 202 as previously
reported [10]. The tetrasaccharide backbone structure of
Table 3. Backbone Sequences Identified by ESI-CID-MS/MS and the Proposed Monosialylated Glycans from Bovine Brain Gangliosides
Fraction Glycans Sequences
Ganglio-series
8 GM1a-glycan Galβ1-3GalNAcβ1-4Galβ1-4Glc
α2-3
NeuAc
10a GM1a(NeuGc)-glycan Galβ1-3GalNAcβ1-4Galβ1-4Glc
α2-3
NeuGc
10c GM1b-glycan Galβ1-3GalNAcβ1-4Galβ1-4Glc
α2-3
NeuAc
10b Fuc-GM1-glycan Galβ1-3GalNAcβ1-4Galβ1-4Glc
α1-2 α2-3
Fuc NeuAc
GalNAc
1-4
11 GalNAc-GM1-glycan Galβ1-3GalNAcβ1-4Galβ1-4Glc
α2-3
NeuAc
Lacto-series
GalNAc
1-4
13 GalNAc2-Lc4 Galβ1-3GlcNAcβ1-3Galβ1-4Glc
α2-3 -4
NeuAc GalNAc
GalNAc
1-4
20 Gal.GalNAc2-Lc4 Galβ1-3GlcNAcβ1-3Galβ1-4Glc
α2-3 -4
NeuAc Gal 1-3GalNAc
Neolacto-series
GalNAc
1-4
12 GalNAc-nLc4 Galβ1-4GlcNAcβ1-3Galβ1-4Glc
α2-3
NeuAc
Backbone sequences of eight glycans released from monosialylated bovine brain glycolipids and assigned by ESI-CID-MS/MS after desialylation, depicted in bold
font. The colors depict the ganglio-series in blue, neolacto-series in green, and lacto-series in red. The tentative assignments of the anomeric configuration, positions,
and linkages of substituent residues, NeuAc, NeuGc, Fuc, and GalNAc, are based on previous knowledge (see references cited within BResults and Discussion^)
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LSTb after desialylation is identical to that of LSTa, and
the spectrum is the same as that shown in Figure 2b.
LSTc and LSTd have the linkage pattern of B4-3-4^ and
therefore the internal 4-linked GlcNAc gave the charac-
teristic 2,4A- and 0,2A-triple ion set. However, for
HexNAc rather than Hex, these are − 101/119/161 rather
than − 60/78/120 due to the -NHAc at the C-2-position
instead of –OH (a 41 Da difference) and appeared at m/z
221/263/281 (Figure 3c).
Clearly, the three tetrasaccharide backbone structures, the
ganglio-, lacto-, and neolacto-series, gave uniquely different
product-ion spectra which can be used for unambiguous as-
signment of the three different tetrasaccharide backbone re-
gions. With this background, for the assignments of the back-
bone regions of the glycans released from bovine brain gangli-
osides, we are making the assumption that the inner monosac-
charide HexNAc in the B3-4-4^ backbones is GalNAc and that
in the B3-3-4^ and the B4-3-4^ it is GlcNAc.
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Figure 5. Negative-ion ESI product-ion spectra of isomeric desialylated pentasaccharides with the ganglio- (a) and neolacto-
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Assignment of Tetrasaccharide Backbones
of Monosialylated Ganglio-Series Glycans
Obtained from Bovine Brain Gangliosides
Molecular ions of three main sialyl glycans, fractions 8,
10c, and 10a, released from the monosialylated bovine
brain gangliosides, are given in Table 2. Those of fractions
8 and 10c are consistent with NeuAc content, and that of
10a with NeuGc. The product-ion spectra of the three
glycans after desialylation are shown in Figure 4a–c, re-
spectively, and these are identical and correspond to the
presence of B3-4-4^ linkages, the same as those of the
GM1a pentasaccharide standard.
Fraction 10b has a [M–H]− ion at m/z 1143 (Table 2),
indicating the presence of an additional monosaccharide
(deoxyhexose) taken as Fuc. After desialylation, the
product-ion spectrum showed a linear pentasaccharide
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sequence with the (deoxyhexose) Fuc at the non-reducing end as
indicated by the C-type ions (Figure 4d). In the pentasaccharide
sequence, the 4-linked Gal next to the reducing Glc is apparent by
the set of − 60/78/120 of the 2,4A4 and 0,2A4 ions at m/z 570/612/
630. Therefore, fraction 10b can be assigned as having a ganglio-
backbone sequencewith the B3-4-4^ linkage pattern (Tables 2 and
3) corresponding to the carbohydrate sequence identified as
fucosyl GM1 [18].
Assignment Isomeric of Pentasaccharides with -
Ganglio- and Neolacto-Backbones from Bovine
Brain Gangliosides
The product-ion spectrum of the desialylated fraction 11 (Fig-
ure 5a) resembled that of Fuc-GM1 (fraction 10b, Figure 4d) with
respect to the ganglio-backbone with B3-4-4^ linkages, char-
acterized by the 4-linked Gal and 4-linked Glc, as shown by the
two sets of − 60/78/120 of the 2,4A4/0,2A4 and 2,4A5/0,2A5 ions
atm/z 627/669/687 and 789/831/849, respectively, in the spec-
trum. The extended GalNAc was tentatively assigned as β1-4
linked to the Gal as has been shown in GalNAc-GM1 isolated
as a very minor brain ganglioside in human brain [19].
The desialylated fraction 12 gave a different spectrum (Fig-
ure 5b), which is reminiscent of that of the neolacto-series shown
in Figure 3c. The main difference between the spectra of fractions
11 and 12 is the internal 4-linkedHexNAc. The fragment ion set at
m/z 424/466/484 arising from neutral loss of − 101/119/161 from
theC3 ion (m/z 585) identified a 4-linkedHexNAc as in the case of
LSTc and LSTd with a B4-3-4^ linkage (Table 2). The extended
HexNAc was considered as GalNAc β1-4 linked to the Gal as the
carbohydrate sequence with neolacto-backbone (Table 3) of gly-
coprotein gangliosides that express the Sda antigen [20].
Assignment of Minor Components with Longer
Chains of the Lacto-Backbone Type
Fractions 13 and 20 are larger glycans with extra HexNAc2
(fraction 13) and Hex1.HexNAc2 residues (fraction 20) on the
tetrasaccharide backbones as evidenced by [M–H]− ions at m/z
1402 and 1565, respectively. In the product-ion spectrum
of fraction 13 (Figure 6a), the C-ions atm/z 220 (C1), 382 (C2),
and 585 (C3) clearly identified a linear HexNAc-Hex-HexNac
sequence. The gap of 365 Da between C3 (m/z 585) and C4 (m/z
950) indicated a HexNAc branch at the non-reducing end. The
lack of other 2,4A/0,2A-type ions in the spectrum, apart from the
reducing terminal 4-linked Glc, suggested a B3-3-4^ linkage
pattern, and therefore, a tetrasaccharide lacto-backbone can be
proposed for fraction 13 (Tables 2 and 3).
The sequence of fraction 20 that can be similarly proposed
as the fragmentation (Figure 6b) is very similar to that of
fraction 13. The only difference is the longer gap, 527 Da,
between C3 (m/z 585) and C4 (m/z 1112) which indicated a
Hex.HexNAc branch at the internal Gal. Again, the lack of
other 2,4A/0,2A-type ions indicated internal B3-3-4^ linkage
pattern; thus, a tetrasaccharide lacto-backbone (Tables 2 and
3) consistent with the glycan structures in gangliosides desig-
nated X1 and X2 isolated previously from bovine brain [21].
Conclusions
The [M–H]− ions before and after desialylation provided
information on the sialic acid type. By negative-ion ESI-
CID-MS/MS [10, 17] analyses after desialylation, a
wealth of sequence and linkage information is obtained
at high sensitivity (1 pmol) on the backbone sequences
of seven of the minor components among the
monosialylated glycans released from bovine ganglio-
sides. However, after chemical desialylation, the informa-
tion on the sialylation site is lost. Conversion of the
carboxyl group of sialic acid into neutral functionalities
by esterification or amidation will be a way forward to
overcome the disadvantage of the present approach.
Fraction 10a was the most abundant in fraction 10. It is the
NeuGc analogue of GM1a which is worthy of comment. This
sialic acid form is reported as lacking in nervous tissue of animals;
its presence in the brain ganglioside extract may represent an
origin from non-neural cell types [22]. This can be resolved in
due course with immuno-histochemical studies. Fuc-GM1 identi-
fied here (fraction 10b) was described as accounting for 1% of
gangliosides extracted from bovine brain [23] and it occurs at
higher levels in the nervous tissue of mini-pig [18].
Fraction 12 is a neolacto-type of glycan, bearing the blood
group Sda carbohydrate, GalNAcβ1-4(NeuAcα2-3)Galβ1-
4GlcNAc, which is abundantly expressed on glycolipids and
glycoproteins in the normal gastrointestinal tract mucosa in
humans, but not to our knowledge among brain gangliosides [22].
The proposed structures of fractions 13 and 20 (Ta-
ble 3) are those of lacto-type glycans and correspond to
gangliosides designated X1 and X2, isolated and charac-
terized as unique lacto gangliosides, isolated previously
from bovine brain [21].
The results give insights into the diversity of glycan struc-
tures present in gangliosides of animal brains. They raise
questions as to the cellular origins of these.
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